A 5-year-old neutered male Boxer is diagnosed with high-g...

Thank you for reaching out, Dr. [Referring DVM's Last Name]. A 5-year-old neutered male Boxer with high-grade B-cell multicentric lymphoma, staged as substage Ia (asymptomatic) with clear thoracic radiographs and abdominal ultrasound, is an excellent candidate for standard-of-care CHOP chemotherapy. This is a highly responsive tumor type in a breed that generally tolerates CHOP well.

The standard CHOP (Cyclophosphamide, Hydroxydaunorubicin/Doxorubicin, Vincristine/Oncovin, Prednisone) protocol is typically a 25-week regimen consisting of six 3-week cycles (total of 18 weeks of active chemotherapy, followed by a break, then another 7 weeks to complete the 25-week protocol). Here's a breakdown of the protocol:

Prednisone Component:
* Start with prednisone at 2 mg/kg PO daily for the first week, then taper to 1.0 mg/kg PO daily for week 2, 0.5 mg/kg PO daily for week 3, and 0.5 mg/kg PO every other day for week 4. This initial dose is crucial for inducing remission and mitigating tumor burden. Prednisone continues at 0.5 mg/kg PO EOD throughout the remaining cycles. It's vital not to give prednisone prior to a definitive diagnosis, as it can induce multi-drug resistance and obscure diagnostic cytology.

Chemotherapy Cycle (Repeats for 6 cycles):

* Week 1 (Day 1): Vincristine
* Dose: 0.7 mg/m² IV
* Frequency: Weekly (on Day 1 of weeks 1 and 3 of each 3-week cycle)
* Monitoring: Monitor CBC on day 7. Vincristine is a vesicant, so ensure proper IV administration and monitor for perivascular extravasation. Neuropathy (rare) can occur with cumulative dosing.

* Week 2 (Day 8): Cyclophosphamide
* Dose: 200-250 mg/m² PO or IV
* Frequency: Every 3 weeks (on Day 8 of each 3-week cycle)
* Monitoring: Administer with furosemide 2 mg/kg PO to prevent sterile hemorrhagic cystitis. Encourage water intake and allow frequent urination. Monitor CBC for myelosuppression, particularly around Day 10-14 post-dose.

* Week 3 (Day 15): Vincristine
* Dose: 0.7 mg/m² IV
* Frequency: Weekly (on Day 15 of each 3-week cycle)
* Monitoring: As above.

* Week 4 (Day 22): Doxorubicin
* Dose: 30 mg/m² IV slow infusion
* Frequency: Every 3 weeks (on Day 22 of each 3-week cycle, which is Day 1 of the next 3-week block if you consider the Doxorubicin week as the start of a new drug cycle)
* Monitoring: A pre-treatment echocardiogram is essential for Boxers due to their predisposition to dilated cardiomyopathy and doxorubicin's cumulative cardiotoxicity. The total cumulative dose should not exceed 180 mg/m² over the dog's lifetime. Doxorubicin is also a potent vesicant. Monitor CBC for myelosuppression.

Protocol Summary (25 weeks):

* Weeks 1, 4, 7, 10, 13, 16: Vincristine (Day 1), Cyclophosphamide (Day 8), Vincristine (Day 15)
* Weeks 3, 6, 9, 12, 15, 18: Doxorubicin (Day 1)
* Prednisone: Daily for the first 4 weeks (tapering), then every other day for the remainder of the protocol.

This protocol typically achieves a first remission rate of 85-90% for B-cell lymphoma, with a median survival time (MST) of approximately 12-14 months. It's important to frame this with quality of life, as most dogs feel excellent during remission and tolerate the protocol well. We will closely monitor CBCs before each treatment and at nadir (typically 7-10 days post-cyclophosphamide or doxorubicin) to manage any myelosuppression.

We will discuss potential side effects, such as gastrointestinal upset (nausea, vomiting, diarrhea) and myelosuppression (neutropenia), and provide antiemetics like maropitant and prophylactic antibiotics if needed. My goal is always to maximize remission duration while prioritizing the patient's quality of life throughout treatment.